ONCOSEC MEDICAL Inc

2023 Q1 Form 10-Q Financial Statement

#000149315223007478 Filed on March 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.683M $25.23M
YoY Change -85.4% -58.18%
Cash & Equivalents $3.683M $25.23M
Short-Term Investments
Other Short-Term Assets $2.758M $2.697M
YoY Change 2.27% 18.81%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $6.442M $27.93M
YoY Change -76.93% -55.39%
LONG-TERM ASSETS
Property, Plant & Equipment $901.8K $6.220M
YoY Change -85.5% -5.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $562.3K $527.7K
YoY Change 6.55% 59.92%
Total Long-Term Assets $2.430M $7.161M
YoY Change -66.07% -3.35%
TOTAL ASSETS
Total Short-Term Assets $6.442M $27.93M
Total Long-Term Assets $2.430M $7.161M
Total Assets $8.871M $35.09M
YoY Change -74.72% -49.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.203M $4.991M
YoY Change -75.89% -48.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $379.5K $497.2K
YoY Change -23.67% -37.85%
Total Short-Term Liabilities $7.231M $5.572M
YoY Change 29.79% -48.41%
LONG-TERM LIABILITIES
Long-Term Debt $1.913M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $5.214M $9.703M
YoY Change -46.26% -9.66%
Total Long-Term Liabilities $7.127M $9.703M
YoY Change -26.55% -12.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.231M $5.572M
Total Long-Term Liabilities $7.127M $9.703M
Total Liabilities $14.36M $15.27M
YoY Change -6.0% -30.13%
SHAREHOLDERS EQUITY
Retained Earnings -$301.0M
YoY Change
Common Stock $295.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.500M $19.82M
YoY Change
Total Liabilities & Shareholders Equity $8.871M $35.09M
YoY Change -74.72% -49.88%

Cashflow Statement

Concept 2023 Q1 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001444307
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 ONCS Convertible Note Related Party Non Current
ConvertibleNoteRelatedPartyNonCurrent
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q1 ONCS Stock Issued During Period Vallue Reverse Split Fractional Shares
StockIssuedDuringPeriodVallueReverseSplitFractionalShares
usd
ONCS Stock Issued During Period Vallue Reverse Split Fractional Shares
StockIssuedDuringPeriodVallueReverseSplitFractionalShares
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
ONCS Amortization Of Issuance Costs Of Convertible Note Related Party
AmortizationOfIssuanceCostsOfConvertibleNoteRelatedParty
usd
ONCS Deferred Offering Costs Written Off
DeferredOfferingCostsWrittenOff
usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
usd
us-gaap Proceeds From Sale Of Other Property Plant And Equipment
ProceedsFromSaleOfOtherPropertyPlantAndEquipment
usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
ONCS Proceeds From Issuance Of Convertible Note Related Party
ProceedsFromIssuanceOfConvertibleNoteRelatedParty
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
ONCS Proceeds From Exercise Of Prefunded Warrants
ProceedsFromExerciseOfPrefundedWarrants
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
ONCS Increase In Rightofuse Assets And Operating Lease Liabilities
IncreaseInRightofuseAssetsAndOperatingLeaseLiabilities
usd
ONCS Amounts Accrued For Offering Costs
AmountsAccruedForOfferingCosts
usd
CY2022Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
usd
CY2022Q3 ONCS Accrued Retention Bonus
AccruedRetentionBonus
usd
CY2023Q1 us-gaap Defined Benefit Pension Plan Liabilities Current
DefinedBenefitPensionPlanLiabilitiesCurrent
usd
CY2022Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P3Y
CY2022Q3 ONCS Convertible Note Related Party Gross
ConvertibleNoteRelatedPartyGross
usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
usd
CY2022Q3 ONCS Subtotal
Subtotal
usd
CY2022Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
usd
CY2022Q3 ONCS Convertible Note Related Party
ConvertibleNoteRelatedParty
usd
CY2023Q1 ONCS Convertible Note Related Party Current
ConvertibleNoteRelatedPartyCurrent
usd
CY2022Q3 ONCS Convertible Note Related Party Current
ConvertibleNoteRelatedPartyCurrent
usd
CY2022Q3 ONCS Convertible Note Related Party Non Current
ConvertibleNoteRelatedPartyNonCurrent
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-01-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54318
dei Entity Registrant Name
EntityRegistrantName
ONCOSEC MEDICAL INCORPORATED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0573252
dei Entity Address Address Line1
EntityAddressAddressLine1
820 BEAR TAVERN ROAD
dei Entity Address City Or Town
EntityAddressCityOrTown
EWING
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08628
dei City Area Code
CityAreaCode
(855)
dei Local Phone Number
LocalPhoneNumber
662-6732
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
ONCS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2971246 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3683330 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12299740 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2758245 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2932731 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
6441575 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
15232471 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
901844 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
978614 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
343588 usd
CY2022Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
378529 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
621827 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4665515 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
562308 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
623239 usd
CY2023Q1 us-gaap Assets
Assets
8871142 usd
CY2022Q3 us-gaap Assets
Assets
21878368 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4690271 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4208222 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1203119 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
376977 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
958118 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1111571 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
379535 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
936558 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7231043 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6633328 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
213835 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4126636 usd
CY2023Q1 ONCS Convertible Note Related Party Non Current
ConvertibleNoteRelatedPartyNonCurrent
1912725 usd
CY2023Q1 ONCS Liability Under Co Promotion Agreement Related Party
LiabilityUnderCoPromotionAgreementRelatedParty
5000000 usd
CY2022Q3 ONCS Liability Under Co Promotion Agreement Related Party
LiabilityUnderCoPromotionAgreementRelatedParty
5000000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
14357603 usd
CY2022Q3 us-gaap Liabilities
Liabilities
15759964 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4545455 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2971197 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2971197 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1790051 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1790051 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
297 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
179 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
295239501 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
291828679 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
153684 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
247211 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-300879943 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-285957665 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-5486461 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
6118404 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8871142 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21878368 usd
CY2022Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 22 reverse stock split
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4653595 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6825540 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9421968 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13471311 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3009912 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2590893 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5548409 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5860616 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7663507 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9416433 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14970377 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-19331927 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14636 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2583 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23463 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4594 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
33551 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
5382 usd
us-gaap Interest Expense
InterestExpense
44632 usd
us-gaap Interest Expense
InterestExpense
13427 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
853764 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-480072 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
72218 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-363147 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6857930 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9904470 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14919328 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19713095 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2950 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2950 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2950 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2950 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6860880 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9907420 usd
us-gaap Net Income Loss
NetIncomeLoss
-14922278 usd
us-gaap Net Income Loss
NetIncomeLoss
-19716045 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.65
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.82
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.05
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2587341 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1787039 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2188821 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1783913 shares
CY2022Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 22 reverse stock split
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6860880 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9907420 usd
us-gaap Net Income Loss
NetIncomeLoss
-14922278 usd
us-gaap Net Income Loss
NetIncomeLoss
-19716045 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-745222 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
383376 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-93527 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
252983 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7606102 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9524044 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15015805 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19463062 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-984449 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
284216 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-490 usd
CY2023Q1 ONCS Adjustments To Additional Paid In Capital Tax Shares Sold To Pay For Tax Withholdings On Equity Awards
AdjustmentsToAdditionalPaidInCapitalTaxSharesSoldToPayForTaxWithholdingsOnEquityAwards
465 usd
CY2023Q1 ONCS Stock Issued During Period Value New Issues One
StockIssuedDuringPeriodValueNewIssuesOne
2819728 usd
CY2023Q1 ONCS Stock Issued During Period Value Prefund Warrants Exercised
StockIssuedDuringPeriodValuePrefundWarrantsExercised
92 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
79 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-745222 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6860880 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-5486461 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
6118404 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
591246 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-3136 usd
ONCS Adjustments To Additional Paid In Capital Tax Shares Sold To Pay For Tax Withholdings On Equity Awards
AdjustmentsToAdditionalPaidInCapitalTaxSharesSoldToPayForTaxWithholdingsOnEquityAwards
2931 usd
ONCS Stock Issued During Period Value New Issues One
StockIssuedDuringPeriodValueNewIssuesOne
2819728 usd
ONCS Stock Issued During Period Value Prefund Warrants Exercised
StockIssuedDuringPeriodValuePrefundWarrantsExercised
92 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
79 usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-93527 usd
us-gaap Net Income Loss
NetIncomeLoss
-14922278 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-5486461 usd
CY2022Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 22 reverse stock split
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
28778694 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
356667 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-4886 usd
CY2022Q1 ONCS Adjustments To Additional Paid In Capital Tax Shares Sold To Pay For Tax Withholdings On Equity Awards
AdjustmentsToAdditionalPaidInCapitalTaxSharesSoldToPayForTaxWithholdingsOnEquityAwards
4762 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
202800 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1185 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
383376 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9907420 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
19815178 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
38075801 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
956574 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-33005 usd
ONCS Adjustments To Additional Paid In Capital Tax Shares Sold To Pay For Tax Withholdings On Equity Awards
AdjustmentsToAdditionalPaidInCapitalTaxSharesSoldToPayForTaxWithholdingsOnEquityAwards
32385 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
42500 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
202800 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1185 usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
252983 usd
us-gaap Net Income Loss
NetIncomeLoss
-19716045 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
19815178 usd
CY2022Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 22 reverse stock split
us-gaap Net Income Loss
NetIncomeLoss
-14922278 usd
us-gaap Net Income Loss
NetIncomeLoss
-19716045 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
124840 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
129959 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
199534 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
325316 usd
us-gaap Share Based Compensation
ShareBasedCompensation
591246 usd
us-gaap Share Based Compensation
ShareBasedCompensation
956574 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
42500 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
72218 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-363147 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1674 usd
ONCS Amortization Of Issuance Costs Of Convertible Note Related Party
AmortizationOfIssuanceCostsOfConvertibleNoteRelatedParty
9450 usd
ONCS Deferred Offering Costs Written Off
DeferredOfferingCostsWrittenOff
39794 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-221429 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-508205 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-62218 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
290876 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
389296 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2118642 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
826142 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
262186 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-222100 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-343817 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
16667 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12737654 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19881493 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15955 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
244857 usd
us-gaap Proceeds From Sale Of Other Property Plant And Equipment
ProceedsFromSaleOfOtherPropertyPlantAndEquipment
4500 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11455 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-244857 usd
ONCS Proceeds From Issuances Or Sale Of Equity
ProceedsFromIssuancesOrSaleOfEquity
79 usd
ONCS Proceeds From Issuances Or Sale Of Equity
ProceedsFromIssuancesOrSaleOfEquity
1185 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
113391 usd
ONCS Proceeds From Issuance Of Convertible Note Related Party
ProceedsFromIssuanceOfConvertibleNoteRelatedParty
2000000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3499909 usd
ONCS Payment Of Financing And Offering Costs
PaymentOfFinancingAndOfferingCosts
673702 usd
ONCS Payment Of Financing And Offering Costs
PaymentOfFinancingAndOfferingCosts
15500 usd
ONCS Proceeds From Exercise Of Prefunded Warrants
ProceedsFromExerciseOfPrefundedWarrants
92 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
202800 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
557023 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
736910 usd
ONCS Repayment Of Tax Withholdings Paid On Equity Awards
RepaymentOfTaxWithholdingsPaidOnEquityAwards
3136 usd
ONCS Repayment Of Tax Withholdings Paid On Equity Awards
RepaymentOfTaxWithholdingsPaidOnEquityAwards
33005 usd
ONCS Tax Shares Sold To Pay For Tax Withholdings On Equity Awards
TaxSharesSoldToPayForTaxWithholdingsOnEquityAwards
2931 usd
ONCS Tax Shares Sold To Pay For Tax Withholdings On Equity Awards
TaxSharesSoldToPayForTaxWithholdingsOnEquityAwards
32385 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4155759 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-549045 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-23060 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-44845 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8616410 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20720240 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12299740 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
45951233 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3683330 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25230993 usd
us-gaap Interest Paid Net
InterestPaidNet
18516 usd
us-gaap Interest Paid Net
InterestPaidNet
13427 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2950 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2950 usd
ONCS Increase In Rightofuse Assets And Operating Lease Liabilities
IncreaseInRightofuseAssetsAndOperatingLeaseLiabilities
3844154 usd
ONCS Amounts Accrued For Offering Costs
AmountsAccruedForOfferingCosts
86494 usd
CY2022Q4 ONCS Restructuring Plan Description
RestructuringPlanDescription
45%, or 17 employees
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-22
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z1Dlc7FcXcD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zsCj0rruTock">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts in the condensed consolidated financial statements and the notes thereto have been reclassified where necessary to conform to the current year presentation. These reclassifications did not affect the prior period total assets, total liabilities, stockholders’ equity (deficit), net loss or net cash used in operating activities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zT5EbiBF2wei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_z0nrKMbsRbr9">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. GAAP, which requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant accounting estimates related to the Company’s ability to continue as a going concern and certain calculations related to that determination. The Company bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. On an ongoing basis, the Company reviews its estimates to ensure that they appropriately reflect changes in the business or as new information becomes available. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zhTL2AjGyYy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zxicn8zHhlpb">Concentrations and Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash balances at a small number of financial institutions in both the United States and Australia and such balances commonly exceed the $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_c20230131_z0Q1JZaJNaPi" title="Cash FDIC insured amount">250,000</span> amount insured by the Federal Deposit Insurance Corporation and $<span id="xdx_907_ecustom--AmountIssuedInsuredAustralianFinancialClaims_iI_uAUD_c20230131_zDyx91K9tD8i" title="Amount issued insured australian financial claims">250,000</span> AUD (approximately $<span id="xdx_908_ecustom--AmountIssuedInsuredAustralianFinancialClaims_iI_uUSD_c20230131_zsBkfuxx3r84" title="Amount issued insured australian financial claims">177,000</span> USD) insured by the Australian Financial Claims Scheme. The Company has not experienced any losses in such accounts and Management believes that the Company does not have significant credit risk with respect to such cash and cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q1 ONCS Amount Issued Insured Australian Financial Claims
AmountIssuedInsuredAustralianFinancialClaims
250000 aud
CY2023Q1 ONCS Amount Issued Insured Australian Financial Claims
AmountIssuedInsuredAustralianFinancialClaims
177000 usd
CY2023Q1 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
5000 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1722181 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1722181 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
192356 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
192356 shares
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.485 pure
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-301000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2538919 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2532800 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1637075 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1554186 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
901844 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
978614 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
45000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
90000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
48000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
95000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
495000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
495000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
151412 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
116471 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
343588 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
378529 usd
CY2020Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P85M
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
34941 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
69882 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
69882 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
69882 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
69882 usd
CY2023Q1 ONCS Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
29119 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
343588 usd
CY2023Q1 ONCS Research And Development Costs
ResearchAndDevelopmentCosts
3594633 usd
CY2022Q3 ONCS Research And Development Costs
ResearchAndDevelopmentCosts
3210627 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
826751 usd
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
877411 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
268887 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
120184 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4690271 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4208222 usd
CY2023Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
320737 usd
CY2022Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
311662 usd
CY2023Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
448570 usd
CY2023Q1 ONCS Accrued Retention Bonus
AccruedRetentionBonus
318102 usd
CY2022Q3 us-gaap Defined Benefit Pension Plan Liabilities Current
DefinedBenefitPensionPlanLiabilitiesCurrent
7333 usd
CY2023Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
115710 usd
CY2022Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
57982 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1203119 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
376977 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
379535 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
936558 usd
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-22
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0407 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0409 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0069 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0130 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.8996 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.9175 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.8698 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.9074 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
27.18
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2710 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
75.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1379 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
76.60
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
1282 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
69.52
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
49 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
168.08
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
118979 shares
CY2023Q1 ONCS Common Stock Reserved For Restricted Stock Unit Release
CommonStockReservedForRestrictedStockUnitRelease
49 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
91597 shares
CY2023Q1 ONCS Common Stock Reserved For Warrant Exercise
CommonStockReservedForWarrantExercise
1242564 shares
CY2023Q1 ONCS Shares Issuable Under Cgp And Sirtex Stock Purchase Agreements
SharesIssuableUnderCgpAndSirtexStockPurchaseAgreements
85585 shares
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
360589 usd
CY2023Q1 ONCS Common Stock Reserved For Future Employee Stock Purchase Plan Issuance
CommonStockReservedForFutureEmployeeStockPurchasePlanIssuance
1176 shares
CY2023Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1900539 shares
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
120000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
120000 usd
CY2023Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2025-12-31
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
313000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
313000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
363000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
363000 usd
CY2023Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-09-30
CY2023Q1 ONCS Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
3361000 usd
CY2023Q1 ONCS Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
3361000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
621827 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4665515 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
958118 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1111571 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
213835 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4126636 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1171953 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
5238207 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
374625 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
753741 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
374625 usd
us-gaap Lease Cost
LeaseCost
753741 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0999 pure
CY2023Q1 ONCS Cash Paid For Operating Lease Liabilities
CashPaidForOperatingLeaseLiabilities
385883 usd
ONCS Cash Paid For Operating Lease Liabilities
CashPaidForOperatingLeaseLiabilities
776307 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
385883 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
776307 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
734733 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
342309 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
122045 usd
CY2023Q1 ONCS Lessee Operating Lease Liability Payments Due There After
LesseeOperatingLeaseLiabilityPaymentsDueThereAfter
50852 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1249939 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
77986 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1171953 usd
CY2012Q2 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
1 pure
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1 pure
CY2023Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
9000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
54000 usd
CY2022Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
28000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
81000 usd
CY2021Q1 ONCS Outstanding Shares Percent
OutstandingSharesPercent
0.42 pure
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.10 pure
CY2022Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-11-25
CY2022Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.10 pure
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
360589 usd
CY2022Q4 ONCS Common Stock Percentage
CommonStockPercentage
0.1999 pure
CY2022Q4 ONCS Average Closing Bid Price
AverageClosingBidPrice
44.00 shares
CY2022Q4 ONCS Incurred Fees And Costs
IncurredFeesAndCosts
113391 usd
CY2023Q1 ONCS Convertible Note Related Party Gross
ConvertibleNoteRelatedPartyGross
2000000 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
16667 usd
CY2023Q1 ONCS Subtotal
Subtotal
2016667 usd
CY2023Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
103942 usd
CY2023Q1 ONCS Convertible Note Related Party
ConvertibleNoteRelatedParty
1912725 usd
CY2023Q1 ONCS Convertible Note Related Party Non Current
ConvertibleNoteRelatedPartyNonCurrent
1912725 usd
CY2023Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
17000 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
17000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2500000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-5500000 usd

Files In Submission

Name View Source Status
oncs-20230131_def.xml Edgar Link unprocessable
0001493152-23-007478-index-headers.html Edgar Link pending
0001493152-23-007478-index.html Edgar Link pending
0001493152-23-007478.txt Edgar Link pending
0001493152-23-007478-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
oncs-20230131_cal.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
oncs-20230131.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
oncs-20230131_lab.xml Edgar Link unprocessable
oncs-20230131_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending